Wednesday, November 28, 2012- Who Wins With Generic Lipitor Recall?at Motley Fool (Wed, Nov 28)
- Elan Starts Phase II AD StudyZacks (Wed, Nov 28)
- Should the Cystic Fibrosis Foundation Invest $58 Million in Pfizer Research?at Forbes (Wed, Nov 28)
- Buy GlaxoSmithKline For 5.3% Dividend Yield, 10% Price Appreciationat Seeking Alpha (Wed, Nov 28)
- SAC Capital Could Face Civil Charges Over Insider Trading: Reportat Forbes (Wed, Nov 28)
- Abbott's Humira's Label ExpandedZacks (Wed, Nov 28)
- Ranbaxy: The Pitfalls of Generic Drug Dependenceat Forbes (Wed, Nov 28)
- Why Bristol-Myers Is Worth a Lookat Motley Fool (Wed, Nov 28)
- Pfizer completes acquisition of NextWave PharmaAP (Wed, Nov 28)
- BP Temporarily Banned From New U.S. Government Contractsat Fox Business (Wed, Nov 28)
- 5 Dividend Picks From Billionaire Stanley Druckenmillerat Motley Fool (Wed, Nov 28)
- Pfizer acquires NextWave Pharmaceuticalstheflyonthewall.com (Wed, Nov 28)
- Pfizer Acquires NextWave Pharmaceuticals, Inc.Business Wire (Wed, Nov 28)
- Cramer's Lightning Round - Pfizer Is Fine (11/27/12)at Seeking Alpha (Wed, Nov 28)
Tuesday, November 27, 2012- This Healtcare Giant Offers a Very Sustainable Yield of Above 4%at Motley Fool (Tue, Nov 27)
- [video] Lightning Roundat CNBC (Tue, Nov 27)
- 1 More Milestone for This Blockbuster Drugat Motley Fool (Tue, Nov 27)
- ACETO Debuts Generic, BioCryst Sees IND Put On Hold: Healthcare Business Recapat Wall St. Cheat Sheet (Tue, Nov 27)
- 5 Ways to Play the Fiscal Cliffat Motley Fool (Tue, Nov 27)
- Theravance’s Vibativ May Have Risk for Pneumonia Patientsat Bloomberg (Tue, Nov 27)
- Retirement Income Planning: The Basicsat Motley Fool (Tue, Nov 27)
- Q3 2012 Pharma Company Updates Indicate Upcoming Catalystsat Seeking Alpha (Tue, Nov 27)
- Third Time's the Charmat Motley Fool (Tue, Nov 27)
- Pall Downgraded to Hold and 4 Downgraded Stocks to Eyeat Wall St. Cheat Sheet (Tue, Nov 27)
- Buy Novartis: A Dividend Gem In The Pharmaceutical Industryat Seeking Alpha (Tue, Nov 27)
Add PFE News to My Yahoo!  | |
|